Head-to-head comparison of six commercial artificial intelligence algorithms for embryo ploidy risk stratification in 1000 PGT-A-tested blastocysts
{{output}}
Research question: Do commercial artificial intelligence (AI)-based embryo assessment algorithms differ in their ability to stratify the risk of embryo ploidy, or do they converge towards a similar level of discrimination despite... ...
